Literature DB >> 29417381

Pancreatic cancer: risk and preventive factors.

Anna Licata1, Giuseppe Montalto2, Maurizio Soresi2.   

Abstract

Entities:  

Mesh:

Year:  2018        PMID: 29417381     DOI: 10.1007/s11739-018-1795-0

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN: 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  20 in total

1.  Statin use and risk of pancreatic cancer: results from a large, clinic-based case-control study.

Authors:  Evan J Walker; Andrew H Ko; Elizabeth A Holly; Paige M Bracci
Journal:  Cancer       Date:  2015-02-03       Impact factor: 6.860

2.  Exploring the relationship between nonalcoholic fatty liver disease and pancreatic cancer by computed tomographic survey.

Authors:  Chao-Feng Chang; Yu-Chen Tseng; Hsin-Hung Huang; Yu-Lueng Shih; Tsai-Yuan Hsieh; Hsuan-Hwai Lin
Journal:  Intern Emerg Med       Date:  2017-12-12       Impact factor: 3.397

3.  Nonalcoholic fatty liver and metabolic syndrome in Italy: results from a multicentric study of the Italian Arteriosclerosis society.

Authors:  Maurizio Soresi; Davide Noto; Angelo B Cefalù; Scipione Martini; Giovanni Battista Vigna; Maurizio Fonda; Enzo Manzato; Luigi Cattin; Renato Fellin; Maurizio R Averna; Alberto Notarbartolo
Journal:  Acta Diabetol       Date:  2012-06-09       Impact factor: 4.280

4.  Metabolic syndrome and pancreatic cancer risk: a case-control study in Italy and meta-analysis.

Authors:  Valentina Rosato; Alessandra Tavani; Cristina Bosetti; Claudio Pelucchi; Renato Talamini; Jerry Polesel; Diego Serraino; Eva Negri; Carlo La Vecchia
Journal:  Metabolism       Date:  2011-05-06       Impact factor: 8.694

5.  Nonalcoholic fatty pancreas disease and Nonalcoholic fatty liver disease: more than ectopic fat.

Authors:  C Della Corte; A Mosca; F Majo; V Lucidi; N Panera; E Giglioni; L Monti; L Stronati; A Alisi; V Nobili
Journal:  Clin Endocrinol (Oxf)       Date:  2015-08-12       Impact factor: 3.478

Review 6.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

7.  Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.

Authors:  Lucia Pacifico; Michele Di Martino; Caterina Anania; Gian Marco Andreoli; Mario Bezzi; Carlo Catalano; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

8.  Cigarette smoking, environmental tobacco smoke exposure and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Authors:  Alina Vrieling; H Bas Bueno-de-Mesquita; Hendriek C Boshuizen; Dominique S Michaud; Marianne T Severinsen; Kim Overvad; Anja Olsen; Anne Tjønneland; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Rudolf Kaaks; Sabine Rohrmann; Heiner Boeing; Ute Nöthlings; Antonia Trichopoulou; Eftihia Moutsiou; Vardis Dilis; Domenico Palli; Vittorio Krogh; Salvatore Panico; Rosario Tumino; Paolo Vineis; Carla H van Gils; Petra H M Peeters; Eiliv Lund; Inger T Gram; Laudina Rodríguez; Antonio Agudo; Nerea Larrañaga; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Jonas Manjer; Björn Lindkvist; Malin Sund; Weimin Ye; Sheila Bingham; Kay-Tee Khaw; Andrew Roddam; Tim Key; Paolo Boffetta; Eric J Duell; Mazda Jenab; Valentina Gallo; Elio Riboli
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

9.  Reliability of the bright liver echo pattern in diagnosing steatosis in patients with cryptogenic and HCV-related hypertransaminasaemia.

Authors:  M Soresi; L Giannitrapani; A M Florena; E La Spada; V Di Gesaro; F Rappa; A Alessandri; S Tripi; M Romano; G Montalto
Journal:  Clin Radiol       Date:  2009-10-08       Impact factor: 2.350

10.  Aspirin might reduce the incidence of pancreatic cancer: A meta-analysis of observational studies.

Authors:  Yan-Peng Zhang; You-Dong Wan; Yu-Ling Sun; Jian Li; Rong-Tao Zhu
Journal:  Sci Rep       Date:  2015-10-21       Impact factor: 4.379

View more
  2 in total

1.  Risk factors and prognostic index model for pancreatic cancer.

Authors:  Hui Huang; Jichun Sun; Zheming Jiang; Xianlin Zhang; Zheng Li; Hongwei Zhu; Xiao Yu
Journal:  Gland Surg       Date:  2022-01

Review 2.  Targeting PI3K/AKT/mTOR Signaling Pathway in Pancreatic Cancer: From Molecular to Clinical Aspects.

Authors:  Silviu Stanciu; Florentina Ionita-Radu; Constantin Stefani; Daniela Miricescu; Iulia-Ioana Stanescu-Spinu; Maria Greabu; Alexandra Ripszky Totan; Mariana Jinga
Journal:  Int J Mol Sci       Date:  2022-09-04       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.